Global Markets and Technologies for Pandemic Control

Report Highlights

The global infectious diseases market reached $238.5 billion in 2022 and should reach $300.8 billion by 2027, with a compound annual growth rate (CAGR) of 4.7% during the forecast period of 2022-2027.

Report Includes

• 22 data tables and 36 additional tables
• A brief general outlook and in-depth analysis of the current and future global markets for pandemics (infectious diseases) control
• Analyses of the global market trends, with market revenue (sales figures) for 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
• Discussion of industry growth driving factors and major technology issues and challenges affecting the market for pandemics control as a basis for projecting demand in the next few years (2023-2028)
• Estimation of the actual market size and revenue forecast for global market for pandemic control in USD million values, and corresponding market share analysis based on the disease type, therapeutics, vaccines, diagnosis, end user, and region
• Assessment of the market growth opportunities, SWOT analysis of the leading companies engaged in development of infectious disease products and viral vaccines, regulatory environment, pipeline analysis, recent approvals, emerging trends and technologies, and the COVID-19 impact on the marketplace
• Review of the key patent grants and patent applications on the market for pandemic control
• Insight into the recent industry structure, competitive aspects of each product segment, increasing investment on R&D activities, market development strategies, and company revenue share analysis
• Identification of major stakeholders and analysis of the company competitive landscape based on their recent developments, financial performance, segmental revenues, and operational integration
• Company profiles of major players within the industry, including Abbott, F. Hoffmann-La Roche, Johnson & Johnson, Merck & Co., and Pfizer

Report Scope

The scope of this study encompasses an investigation of the current pandemics. BCC Research analyzes each disease type, determines its current market status based on the available or approved diagnostic methods for the disease, type of intervention approved (therapeutic or vaccine) and estimates the current market for each pandemic disease. It also examines the future market for the diseases and presents forecasts of growth over the next six years.

The current report provides detailed analysis of the market's drivers, challenges and opportunities. The report also covers market projections to 2027 and market share for key market players. The report includes the company profiles of the key players with detailed information about business segments, financials, product portfolios and recent developments. The report also provides the impact of the COVID-19 pandemic on this market.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.